Show simple item record

dc.contributor.advisorValderrama Beltrán, Sandra Liliana
dc.creatorZhong Lin, Alberto
dc.date.accessioned2019-05-21T13:19:11Z
dc.date.available2019-05-21T13:19:11Z
dc.date.created2018
dc.identifier.urihttp://hdl.handle.net/10554/42996
dc.publisherPontificia Universidad Javerianaspa
dc.rightsAtribución-NoComercial-SinDerivadas 2.5 Colombia*
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/2.5/co/*
dc.titleRisk factors associated with methicillin-resistant staphylococcus aureus skin and soft tissue infections in Colombiaspa
dc.subject.lembEspecialización en medicina interna - Tesis y disertaciones académicasspa
dc.subject.lembInfecciones por estafilococosspa
dc.subject.lembInfecciones de la pielspa
dc.type.spaTrabajo de gradospa
dc.publisher.departmentFacultad de Medicinaspa
dc.publisher.programEspecialización en Medicina Internaspa
dc.description.abstractenglishObjectives: MRSA Skin and soft tissue infections represent a major clinical problem in Colombia. The aim of this study was to evaluate risk factors associated with MRSA SSTI in Colombia. Methods: We performed a multicenter cohort study with nested case-control design. Patients with SSTI with at least 48 hours of inpatient care were included. Patients with MRSA SSTI were considered the case group and patients with either non-MRSA SSTI or with MSSA SSTI were the control groups. We used multivariate logistic regression approach to evaluate risk factors associated with MRSA SSTI using two different statistical models. Results: We included 1,134 patients. Cultures were available for 706 patients of which 36.7% (n=259) were Staphylococcus aureus. MRSA was confirmed in 68.3% of the S. aureus cultures. In the first model independent risk factors for MRSA SSTI were presence of abscesses (P<.0001), furunculosis (P= .044), age 18 - 44 years (P= <0.0001), prior outpatient treatment in the preceding index visit (P=.010) and report of an insect bite (P=.027). In the second model the main risk factor found was prior outpatient treatment in the preceding index visit (P= .013). Conclusions: Although clinicians should consider MRSA when designing the initial empirical treatment for purulent SSTI in Colombia.spa
dc.subject.subjectenglishStaphylococcal skin infectionsspa
dc.subject.subjectenglishMethicillin-Resistant Staphylococcus aureusspa
dc.subject.subjectenglishRisk factorsspa
dc.subject.subjectenglishAbscessspa


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record

Atribución-NoComercial-SinDerivadas 2.5 Colombia
Except where otherwise noted, this item's license is described as Atribución-NoComercial-SinDerivadas 2.5 Colombia